Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

NEIL1 Inhibitors

NEIL1 inhibitors represent a class of chemical compounds that are specifically engineered to modulate the activity of the NEIL1 enzyme. NEIL1, a member of the DNA glycosylase family, functions as a vital player in the DNA repair machinery. Its primary role is to recognize and excise damaged or oxidized DNA bases, initiating the base excision repair pathway. This pathway is crucial for maintaining the integrity of the genome by rectifying a range of DNA lesions caused by oxidative stress, environmental factors, or endogenous cellular processes. The design and development of NEIL1 inhibitors involve a detailed understanding of the enzyme's structural attributes and its mode of substrate recognition and binding. Inhibitors are meticulously tailored molecules that are strategically crafted to fit into the active site of NEIL1, thus hindering its enzymatic function. This binding interaction obstructs the enzyme's ability to efficiently identify and process damaged DNA bases, thereby affecting its role in the DNA repair process.

Researchers in the field of DNA repair and chemical biology employ NEIL1 inhibitors as valuable tools to investigate the enzyme's functions, mechanisms, and interactions within the context of cellular DNA repair pathways. By impeding NEIL1's activity, scientists can gain insights into how its inhibition influences the broader cellular response to DNA damage and repair, as well as the potential implications for genome stability and cellular homeostasis. The development and study of NEIL1 inhibitors are intertwined with advancing knowledge in the fields of DNA repair, enzymology, and structural biology. These inhibitors offer a means to explore NEIL1's contribution to genome maintenance, and they contribute to the broader understanding of cellular responses to DNA damage.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AZ20

1233339-22-4sc-503186
5 mg
$255.00
1
(0)

NEIL1 inhibitor identified via high-throughput screening, studied as a potential adjuvant in cancer therapy.